Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/13/2026

Cardiac Stress Test Guidelines

Indications and Contraindications

  • A cardiac stress test should be performed in patients with suspected coronary artery disease (CAD) who have normal initial cardiac biomarkers and ECG, within 72 hours of presentation for low-risk patients or after 8-12 hours of observation for patients in chest pain units if they remain pain-free with normal ECGs and cardiac biomarkers, as recommended by the American College of Cardiology 1
  • Exercise testing is preferred over pharmacological stress testing whenever functional status permits, according to the American Heart Association 2
  • The American College of Cardiology recommends that pharmacological stress testing should be used for patients who cannot exercise adequately 1
  • Contraindications to stress testing include acute coronary syndrome, decompensated heart failure, severe/symptomatic aortic stenosis, uncontrolled arrhythmias, severe systemic arterial hypertension, acute aortic dissection, pericarditis/myocarditis, pulmonary embolism, and severe pulmonary hypertension, as stated by the American Heart Association 2
  • The American College of Cardiology states that acute coronary syndrome is a contraindication to stress testing 1

Patient Risk Assessment and Testing Selection

  • The American College of Cardiology recommends a step-by-step approach for CAD assessment, including determining urgency of surgery, assessing for acute coronary syndrome, estimating perioperative risk of major adverse cardiac events, and determining functional capacity 3
  • If a patient has low risk of major adverse cardiac events (<1%), no further testing is needed, according to the American College of Cardiology 3
  • The American Heart Association recommends that if a patient has elevated risk of major adverse cardiac events, functional capacity should be determined, with ≥4 METs indicating no further evaluation is needed 3

Interpretation of Results and Risk Stratification

  • High-risk findings include exercise EF ≤0.50 or rest EF ≤0.35, stress-induced moderate perfusion defect with LV dilation or increased lung uptake, and echocardiographic wall-motion abnormality involving more than 2 segments developing at low dose of dobutamine, as defined by the American Heart Association 4
  • Intermediate-risk findings include mild/moderate resting LV dysfunction, intermediate-risk treadmill score, stress-induced moderate perfusion defect without LV dilation, and limited stress echocardiographic ischemia, according to the American Heart Association 4
  • Low-risk findings include low-risk treadmill score, normal or small myocardial perfusion defect, and normal stress echocardiographic wall motion, as stated by the American Heart Association 4

Common Pitfalls to Avoid

  • The American College of Cardiology recommends against ordering stress tests in asymptomatic low-risk patients without risk factors 1
  • The American Heart Association states that routine preoperative stress testing in low-risk patients or those undergoing low-risk procedures is not recommended 2
  • Failing to consider pharmacologic stress testing when patients cannot achieve adequate exercise levels can lead to inaccurate results, according to the American College of Cardiology 1

Assessment of Patients Requiring Stress Testing

Pre-Test Clinical Evaluation

  • The American Heart Association recommends evaluating resting ECG abnormalities, such as complete left bundle branch block, pre-excitation syndrome, left ventricular hypertrophy, digoxin therapy, >1 mm resting ST-segment depression, or electronically paced ventricular rhythm, and undergoing stress imaging rather than standard exercise ECG in these cases 5
  • The American College of Cardiology suggests identifying high-risk features, such as ongoing chest pain, hemodynamic instability, or high-risk ECG changes, which require hospitalization rather than outpatient stress testing 5

Selection of Stress Testing Modality

  • The American Heart Association recommends exercise stress testing as the preferred initial test for patients with normal or near-normal resting ECG who are capable of adequate exercise, as it provides functional capacity assessment and is less expensive than imaging modalities 5

Specific Clinical Scenarios

  • The American College of Cardiology recommends submaximal stress testing at 4-6 days post-discharge for prognostic assessment, activity prescription, and evaluation of medical therapy in post-myocardial infarction patients 5
  • The American Heart Association suggests symptom-limited stress testing at 14-21 days if predischarge testing was not performed, or at 3-6 weeks if early testing was submaximal in post-myocardial infarction patients 5
  • The American Diabetes Association indicates that evaluation of asymptomatic persons with diabetes who plan to start vigorous exercise is a Class IIa indication for stress testing 5

Preparation and Safety Measures

  • The American Heart Association recommends continuous ECG monitoring with assessment for ST-segment changes, arrhythmias, and heart rate response during stress testing 5
  • The American College of Cardiology suggests blood pressure monitoring at regular intervals to detect hypotension or severe hypertension during stress testing 6
  • The American Heart Association recommends clinical assessment for chest discomfort, dyspnea, dizziness, or other symptoms suggesting inadequate cardiac output during stress testing 5, 6

ACC/AHA Guideline Recommendations for Intermediate‑Risk Surgery in Patients with Poor Functional Capacity (< 4 METs)

Preoperative Cardiac Evaluation

  • Patients who have a functional capacity < 4 METs and no clinical cardiac risk factors should proceed to the planned intermediate‑risk operation without additional cardiac testing (Class I recommendation) 7, 8, 9, 10.
  • When no cardiac risk factors are present, surgery can be performed directly without further evaluation (Class I) 7, 8, 9, 10.
  • If 1–2 cardiac risk factors exist, the operation should be undertaken with heart‑rate control (e.g., β‑blockade); this is a Class IIa recommendation 7, 8, 11.
  • With ≥ 3 cardiac risk factors, proceed with heart‑rate control and consider non‑invasive testing only if the results would alter management (Class IIb) 7, 8, 11.
  • A pre‑operative ECG is required for any patient with cardiac risk factors undergoing intermediate‑risk surgery (Class I) 9, 10.

Intra‑operative Management

  • β‑blockade should be employed to maintain heart‑rate control in patients who have cardiac risk factors 7, 8, 11.
  • Surgical duration should be minimized whenever feasible to accommodate limited functional reserve 7, 8.
  • Fluid administration must balance adequate organ perfusion against the risk of volume overload in low‑MET patients 7, 8.
  • Regional anesthesia (spinal/epidural) is associated with fewer postoperative complications and faster recovery in patients with limited functional capacity 12.

Post‑operative Care

  • Implement enhanced recovery protocols to prevent deconditioning in patients with METs < 4 7, 12.

Critical Pitfalls to Avoid

  • Do not delay surgery for cardiac testing unless the patient has ≥ 3 cardiac risk factors and the testing is expected to change management 7, 8, 11.
  • Routine pre‑operative stress testing is not recommended for patients whose only limitation is poor functional capacity 7.
  • Do not assume that multiple‑sclerosis severity alone increases cardiac risk; risk stratification should be based on functional capacity and cardiac risk factors, not the neurological diagnosis 7, 8, 12.

REFERENCES

1

Indications and Contraindications for Cardiac Stress Testing [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025